
EVENTS

Sable Resources Webinar: Investor Update
Join Adelaide Capital for a webinar featuring Sable Resources!
TSXV: SAE // OTCQB: SBLRF
Sable is a well-funded junior grassroots explorer focused on the discovery of Tier-One new precious metal and copper projects through systematic exploration in endowed terranes located in favorable, established mining jurisdictions. Sable’s focus is developing its large portfolio of new Greenfields projects to resource level. Sable is actively exploring the San Juan Regional Program (163,969 ha) incorporating the Don Julio, El Fierro, and Cerro Negro projects in San Juan Province, Argentina and the Copper Queen (15,133ha), Rusty Peak (1,942 ha), Copper Prince (3,980 ha), and the Core Mountain (1,925 ha) properties in British Columbia.
📩 Have questions? Drop them in the comments or reach out directly: info@adcap.ca
Subscribe to our newsletter so you never miss out on company news or future webinars: https://www.adcap.ca/subscribe

Xali Gold Webinar: New to Adelaide
Join Adelaide Capital for a webinar featuring Xali Gold!
TSXV: XGC
Xali Gold holds several gold and silver projects in both Mexico and Peru. Xali Gold has recently acquired the right to earn a 49% interest in the Sarape silver-gold Project (“Sarape”), in Northern Mexico from Advanced Lithium Corp. The Sarape Project is located in the Rio Sonora Valley of northern Mexico, a prolific gold-silver mining district that includes First Majestic Silver’s Santa Elena/Ermitano Mine, Premier Gold Mines’ Mercedes Mine and SilverCrest Metal’s Las Chispas Mine.
El Oro is a district scale historic producer of gold and silver. While the Company’s main goal at El Oro is to make a new discovery, similar to the multi-million ounce (“oz”) gold and silver ore bodies mined historically, the Company has entered into two agreements with third parties for the rights to produce gold and silver from specific areas of the El Oro Project which are expected to bring in cash flow and open up underground access for drilling.
With renewed interest in gold and silver exploration in South America, Xali Gold has recently been reviewing high sulphidation gold targets with features similar to Yanacocha and Pierina, within proven high sulphidation epithermal belts in Peru. The Company also still maintains other properties in Peru.
📩 Have questions? Drop them in the comments or reach out directly: info@adcap.ca
Subscribe to our newsletter so you never miss out on company news or future webinars: https://www.adcap.ca/subscribe

Maple Gold Mines Webinar: Investor Update
Join Adelaide Capital for a webinar featuring Maple Gold Mines!
TSXV: MGM ♦️ OTCQB: MGMLF ♦️ FSE: M3G
Maple Gold Mines is a Canadian advanced exploration company focused on advancing its 100%-owned, district-scale Douay/Joutel Gold Project located in Québec's prolific Abitibi Greenstone Gold Belt. Douay/Joutel benefits from exceptional infrastructure access and boasts ~400 km2 of highly prospective ground including an established gold mineral resource at Douay with significant expansion potential as well as the past-producing Telbel and Eagle West mines at Joutel. In addition, the Company holds an exclusive option to acquire 100% of the Eagle Mine Property, a key part of the historical Joutel Mining Complex.
Maple Gold's property package also hosts a significant number of regional exploration targets along a 55-km strike length of the Casa Berardi Deformation Zone that have yet to be tested through drilling, making the property ripe for new gold and polymetallic discoveries. The Company is currently focused on carrying out exploration and drill programs to grow mineral resources and make new discoveries to establish an exciting new gold district in the heart of the Abitibi
📩 Have questions? Drop them in the comments or reach out directly: info@adcap.ca
Subscribe to our newsletter so you never miss out on company news or future webinars: https://www.adcap.ca/subscribe

Borealis Mining Webinar: Investor Update
Join Adelaide Capital for a webinar featuring Borealis Mining!
TSXV: BOGO ♦️ FSE: L4B0
Borealis Mining is a gold mining and exploration company focused on the exploration and resumption of production of the Borealis Mine in Nevada. The Borealis Mine is a fully permitted mine site, equipped with active heap leach pads, an ADR facility, and all necessary infrastructure to support a heap leach gold mining operation.
In addition to the mine, the property, comprised of 815 unpatented mining claims (16,300 acres) and one unpatented mill site claim, is highly prospective for additional high-sulfidation gold mineralization.
Gold Bull’s core asset is the Sandman Project, located in Nevada, which has an Indicated Resource of 433k ounces at 0.73 g/t gold and an Inferred Resource of 61k ounces at 0.58 g/t gold (as per the 2021 43-101 Resource Estimate). Sandman is 23 km south of the past-producing Sleeper Mine and has excellent large-scale exploration potential. Gold Bull also owns the Big Balds exploration project in Nevada.
📩 Have questions? Drop them in the comments or reach out directly: info@adcap.ca
Subscribe to our newsletter so you never miss out on company news or future webinars: https://www.adcap.ca/subscribe




Microbix Q1 2025 Earnings Webinar
Join Adelaide Capital for Microbix’s Q1 Earnings Webinar!
TSX: MBX OTCQX: MBXBF
Microbix Biosystems creates proprietary biological products for human health, with over 120 skilled employees and revenues now targeting C$ 2.0 million or more per month. It enables the worldwide commercialization of diagnostic assays by making a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its antigens drive the antibody tests of approximately 100 diagnostics makers, while QAPs are sold to clinical lab accreditation organizations, diagnostics companies, and clinical labs. Microbix QAPs are now available in over 30 countries, supported by a network of international distributors. Microbix is ISO 9001 & 13485 accredited, U.S. FDA registered, Australian TGA registered, Health Canada establishment licensed, and provides IVDR-compliant CE marked products.
Microbix also applies its biological expertise and infrastructure to develop other proprietary products and technologies, most notably Kinlytic® urokinase, a biologic thrombolytic drug used to treat blood clots, and reagents or media to support molecular diagnostic testing (e.g., its DxTM™ for patient-sample collection). Microbix is traded on the TSX and OTCQX, and headquartered in Mississauga, Ontario, Canada.


Mako Mining Webinar
Join Adelaide Capital for a webinar featuring Mako Mining!
Mako Mining (TSXV: MKO, OTCQX: MAKOF) is a publicly listed gold mining, development and exploration company. The Company operates the high-grade San Albino gold mine in Nueva Segovia, Nicaragua, which ranks as one of the highest-grade open pit gold mines globally. Mako's primary objective is to operate San Albino profitably and fund exploration of prospective targets on its district-scale land package. The Company also owns 100% of the gold project Eagle Mountain in Guyana, South America.

Talisker Investor Webinar
Talisker (TSX: TSK, OTCQX: TSKFF) is a junior resource company involved in the exploration and development of gold projects in British Columbia, Canada. Talisker’s flagship asset is the high-grade, fully permitted Bralorne Gold Project where the Company is currently transitioning into underground production at the Mustang Mine. Talisker projects also include the Ladner Gold Project, an advanced stage project with significant exploration potential from an historical high-grade producing gold mine and the Spences Bridge Project where the Company holds ~85% of the emerging Spences Bridge Gold Belt, and several other early-stage Greenfields projects.

Horizon Petroleum Investor Webinar
Join Adelaide Capital for a webinar featuring Horizon Petroleum!
Horizon (TSXV: HPL) is a European-focused development company that boasts a management team with worldwide experience, including Poland, with a track record of reserve, production, and corporate growth. Horizon plans to acquire additional conventional natural gas and oil assets in Europe to take advantage of the high natural gas prices and large natural gas requirements for the region.
The Company recently acquired 100% interest in a conventional natural gas development asset in Poland containing 189Bcfe of 2P reserves plus 2C Risked Contingent Resources with a before-tax NPV10 of USD$460MM in the core area with significant development upside. The initial work program will provide cash flow in 2025. Acquisition costs $1.08MM, C$1MM shares in Horizon, and a profit share of 6%. The first cash flow is expected in 2025 with exponential production growth from currently zero to 30mmcf/day by 2027 and growth expected to continue until 2029.
Horizon is constantly evaluating new development assets in stable, investment-friendly jurisdictions. Europe’s energy needs are growing as Russian gas cut-offs have pushed many countries into states of emergency already this winter. Natural gas will also assist many countries that still rely on coal to transition to a cleaner form of energy for power generation.

Sierra Madre Webinar
Join Adelaide Capital for a webinar featuring Sierra Madre Gold and Silver!
Sierra Madre Gold and Silver (TSXV: SM, OTCQX: SMDRF) is a precious metals producer and exploration company focused on the Guitarra mine in the Temascaltepec mining district, Mexico, and the exploration and development of its Tepic property in Nayarit, Mexico. The Guitarra mine is a permitted, past-producing underground mine, which includes a 500 t/d processing facility that operated until mid-2018.
The +2,600 ha Tepic Project hosts low-sulphidation epithermal gold and silver mineralization with an existing historic resource.
Sierra Madre´s management team has played key roles in managing the exploration and development of more than 22Moz gold and 600Moz silver in combined mineral reserves and mineral resources. Sierra Madre´s team of professionals has collectively raised over $1 billion for mining companies.

Microbix Q4 & Year-End Earnings Webinar
Join Adelaide Capital for Microbix’s Q4 and Year-End Earnings Webinar!
TSX: MBX OTCQX: MBXBF
Microbix Biosystems Inc. creates proprietary biological products for human health, with over 100 skilled employees and sales now targeting C$ 2.0 million monthly.
Microbix makes and exports a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, enable assay development and validation or help ensure the quality of clinical diagnostic workflows. Its antigens drive the antibody tests of approximately 100 diagnostics makers, while QAPs are sold to clinical lab accreditation organizations, diagnostics companies, and clinical labs. Microbix QAPs are now available in over 30 countries, supported by a network of international distributors. Microbix is ISO 9001 & 13485 accredited, U.S. FDA registered, Australian TGA registered, Health Canada establishment licensed, and provides CE-marked products.
Microbix also applies its biological expertise and infrastructure to develop other proprietary products and technologies, most notably Kinlytic® urokinase, a biologic thrombolytic drug used to treat blood clots, and reagents or media to support molecular diagnostic testing (e.g., its DxTM™ for patient-sample collection).
Microbix is traded on the TSX and OTCQX and is headquartered in Mississauga, Ontario, Canada.
Subscribe to Adelaide Capital’s YouTube channel to catch all webinar replays!

Kingfisher Metals Webinar
Join Adelaide Capital for a webinar featuring Kingfisher Metals!
Kingfisher Metals (TSXV: KFR; OTCQB: KGFMF; FSE: 970) is a copper and gold explorer, with a leading presence in the Golden Triangle region of northwest BC. This week, the Company announced the expansion of its flagship HWY 37 project to 819km2, forming the largest contiguous project held by a non-producing company in the Triangle. Both Teck/Newmont’s Galore Creek project, Teck’s Schaft Creek, and Newmont’s Saddle project are adjacent to the Kingfisher tenure.
With the latest acquisition of the BAM property, Kingfisher is adding three grassroots, large-scale porphyry target areas (Northmore, Mess Creek, and Hickman). The new 189 km2 is fully assessed with no holding costs till 2032. Since entering the Golden Triangle in 2023, Kingfisher has been steadily consolidating ground in this prospective region while defining drill targets. In 2025 the Company plans to begin drilling at the Williams Deposit where open ended mineralization has returned 347m @ 0.33% Cu and 0.39 g/t Au including 127 m @ 0.56% Cu and 0.69 g/t Au.

iFabric Investor Webinar
Join Adelaide Capital for iFabric (TSX: IFA, OTCQX: IFABF) Investor Webinar
Headquartered in Markham, Ontario, iFabric, www.ifabriccorp.com, is listed on the TSX and, currently has 30.3 million shares issued and outstanding. Its two strategic divisions offer a variety of products and services through wholly-owned subsidiaries, namely, Intelligent Fabric Technologies (North America) Inc. ("IFTNA") and Coconut Grove Pads Inc. ("Coconut Grove"). IFTNA is focused on development and sale of high-performance sports apparel, medical protective apparel, consumer protective apparel, and proprietary treatments that provide “intelligent” properties to fabrics, foams, plastics, and numerous other surfaces, thereby improving the safety and well-being of the user. Such intelligent properties include antiviral and antibacterial characteristics, water-repellence and UV protection, among others. Coconut Grove, operating as Coconut Grove Intimates, is a designer, manufacturer, distributor, licensor and licensee of ladies’ intimate apparel products and accessories.

Microbix Investor Webinar
Join Adelaide Capital for Intro to Microbix (TSX: MBX, OTCQX: MBXBF) Investor Webinar
This webinar is designed for investors new or newish to Microbix. Cameron Groome, CEO, will walk us through the story and explain the different business divisions and products. There will be a Q&A at the end of the session. Microbix Biosystems Inc. creates proprietary biological products for human health, with over 100 skilled employees and sales now targeting C$ 2.0 million per month. It makes and exports a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its antigens drive the antibody tests of approximately 100 diagnostics makers, while QAPs are sold to clinical lab accreditation organizations, diagnostics companies, and clinical labs. Microbix QAPs are now available in over 30 countries, supported by a network of international distributors. Microbix is ISO 9001 & 13485 accredited, U.S. FDA registered, Australian TGA registered, Health Canada establishment licensed, and provides CE marked products. Microbix also applies its biological expertise and infrastructure to develop other proprietary products and technologies, most notably Kinlytic® urokinase, a biologic thrombolytic drug used to treat blood clots, and reagents or media to support molecular diagnostic testing (e.g., its DxTM™ for patient-sample collection). Microbix is traded on the TSX and OTCQX, and headquartered in Mississauga, Ontario, Canada.

Tantalus Investor Webinar
Join Adelaide Capital for Tantalus Investor Update Webinar
Tantalus (TSX: GRID) is a technology company dedicated to helping utilities modernize their distribution grids by harnessing the power of data across all their devices and systems deployed throughout the entire distribution grid. We offer a grid modernization platform across multiple levels: intelligent connected devices, communications networks, data management, enterprise applications and analytics. Our solutions provide utilities with the flexibility they need to get the most value from existing infrastructure investments while leveraging advanced capabilities to plan for future requirements. Learn more at http://www.tantalus.com/.
